Loading...
Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
BACKGROUND: Depression has a lifetime prevalence of 10%–25% among women and 5%–12% among men. Selective serotonin reuptake inhibitors (SSRIs) are the most used and the most cost-effective treatment for long-term major depressive disorder. Since the introduction of generic SSRIs, the costs of branded...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3570079/ https://ncbi.nlm.nih.gov/pubmed/23413176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S39492 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|